Zika virus: Difference between revisions
3amrbadawy (talk | contribs) No edit summary |
3amrbadawy (talk | contribs) No edit summary |
||
| Line 12: | Line 12: | ||
**South America | **South America | ||
==Clinical Features== | ==Clinical Features<ref>[http://www.cdc.gov/zika/hc-providers/clinicalevaluation.html CDC: Zika Virus: Clinical evaluation and disease]</ref>== | ||
*80% of patients are asymptomatic | |||
*Prodromal sx | |||
**Fever, rash, joint pain, conjunctivitis | |||
**After incubation period of 2-7 days | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Revision as of 01:51, 16 February 2016
Background
- First reported case in US on Jan 13,2016 in patient who returned to Houston,TX after traveling to Latin America[1]
- Transmitted to humans through[2]:
- Travel history is key. Regions with active transmission include[5]:
- Africa
- Carribean
- Central America/Mexico
- Pacific Islands
- South America
Clinical Features[6]
- 80% of patients are asymptomatic
- Prodromal sx
- Fever, rash, joint pain, conjunctivitis
- After incubation period of 2-7 days
Differential Diagnosis
Diagnosis
Management
Disposition
See Also
External Links
References
- ↑ Faccini-Martínez ÁA, Botero-García CA, Benítez-Baracaldo FC, Pérez-Díaz CE. With regard about the case of Dengue, Chikungunya and Zika co-infection in a patient from Colombia. J Infect Public Health. 2016. PMID: 26837723
- ↑ Hayes EB. Zika virus outside Africa. Emerg Infect Dis. 2009;15:1347–50.
- ↑ Musso D, Roche C, Robin E, Nhan T, Teissier A, Cao-Lormeau VM. Potential sexual transmission of Zika virus. Emerg Infect Dis. 2015; 21(2): 359-61. PMID: 25625872
- ↑ Musso D, Nhan T, Robin E, et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill. 2014; 19(14): . PMID: 24739982
- ↑ CDC: Zika Travel Information
- ↑ CDC: Zika Virus: Clinical evaluation and disease